Frances Blevins, PA-C is a board certified Physician Assistant who joined the Solomont Center for Hematology and Medical Oncology in 2015 and works with the hematology team. PA Blevins is an instructor of medicine at Boston University School of Medicine and a preceptor for PA students. She graduated from the Tufts University PA program obtaining her Master of Medical Science.
- Tufts University School of Medicine, MMS/MMSc
- Suffolk University, BS
- Published on 2/25/2022
Milrod CJ, Mann M, Blevins F, Hughes D, Patel P, Li KY, Lerner A, Sanchorawala V, Sloan JM. Underrepresentation of Black participants and adverse events in clinical trials of lenalidomide for myeloma. Crit Rev Oncol Hematol. 2022 Apr; 172:103644. PMID: 35227897.
- Published on 7/1/2021
Hughes DM, Toste C, Nelson C, Escalon J, Blevins F, Shah B. Transitioning From Thrombopoietin Agonists to the Novel SYK Inhibitor Fostamatinib: A Multicenter, Real-World Case Series. J Adv Pract Oncol. 2021 Jul; 12(5):508-517. PMID: 34430061.
- Published on 5/27/2021
Milrod CJ, Blevins F, Hughes D, Lerner A, Sarosiek S, Sanchorawala V, Sloan JM. Incidence of skin hyperpigmentation in Black patients receiving treatment with immunomodulatory drugs. Blood. 2021 05 27; 137(21):2987-2989. PMID: 33728443.
- Published on 11/13/2019
David Hughes, PharmD, Frances Blevins, PA-C, Bhavesh Shah, RPh, Shayna Sarosiek, Adam Lerner, MD, John Mark Sloan, MD. Blood. Real-World Experience with Fostamatinib in Patients with Immune Thrombocytopenia at an Academic Medical Center. ASH Publications. 2019.